Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
Open Access
- 29 May 2022
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 19 (6) , 1023-1028
Abstract
Triple-negative breast cancer (TNBC) is the third most common female cancer in Taiwan. EZH2 plays an important role in cancer development through transcriptional repression by chromatin remodeling. However, the expression of EZH2 in breast cancer is highly correlated with tumorigenesis, and patient survival is not matched to TNBC. Furthermore, it has not been determined if specific EZH2 genetic variants are associated with breast cancer risk. In this paper, we evaluated the survival of different types of breast cancer. The results indicated that a lower expression of EZH2 led to poor survival of TNBC patients. Therefore, we aimed at studying the relationship between genetic polymorphisms of EZH2 and susceptibility to TNBC in Taiwan. Four single-nucleotide polymorphisms (SNPs) of EZH2 (rs6950683, rs2302427, rs3757441, and rs41277434) were analyzed by real-time PCR genotyping in 176 patients with TNBC and 1000 cancer-free controls. The results showed that TNBC patients under 60 years old who carried a TC or CC genotype at EZH2 rs6950683 and re3757441 had a tumor size of 20 mm or smaller (T1). Thus, this study is the first to examine the age and mutant genes associated with EZH2 SNPs in TNBC progression and development in Taiwan.Keywords
This publication has 28 references indexed in Scilit:
- Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular CarcinomaPLOS ONE, 2013
- A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinomaOncology Letters, 2013
- The role of EZH2 in tumour progressionBritish Journal of Cancer, 2011
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in CancerScience, 2008
- Genetic Susceptibility to CancerJAMA, 2008
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008
- MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeGenome Biology, 2007
- Genome Regulation by Polycomb and Trithorax ProteinsCell, 2007
- Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human GenomeScience, 1998